Gene expression variability across the genome has significant impact on understanding the progress and prognosis of cancer. The Cancer Functional Genomics Core at the Stephenson Cancer Center offers cutting-edge technology that can provide extremely accurate and reliable expression data to support drug discovery research. The versatile Agilent SureScan Microarray Scanner system provides the ability to scan genome-wide microarray profiles.
For quality assessment of purified RNA and DNA, there are two instruments that include the Biorad Experion™ Automated Electrophoresis Station and Agilent 2100 Bioanalyzer. The Biorad CFX96™ Touch Real-Time PCR Detection System provides highly-reliable quantitative individual gene transcription profiling. Bio-Rad QX100 Droplet Digital PCR is useful to detect the absolute copy number of the genes.